147 related articles for article (PubMed ID: 32205577)
21. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
Malin SK; Kashyap SR
Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
[TBL] [Abstract][Full Text] [Related]
22. Metabolic and cardiovascular outcomes of bariatric surgery.
Iqbal Z; Adam S; Ho JH; Syed AA; Ammori BJ; Malik RA; Soran H
Curr Opin Lipidol; 2020 Aug; 31(4):246-256. PubMed ID: 32618731
[TBL] [Abstract][Full Text] [Related]
23. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
24. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
25. Bariatric Surgery Resistance: Using Preoperative Lifestyle Medicine and/or Pharmacology for Metabolic Responsiveness.
Gilbertson NM; Paisley AS; Kranz S; Weltman A; Kirby JL; Hallowell PT; Malin SK
Obes Surg; 2017 Dec; 27(12):3281-3291. PubMed ID: 29058238
[TBL] [Abstract][Full Text] [Related]
26. Impact of Bariatric Surgery on Heme Oxygenase-1, Inflammation, and Insulin Resistance in Morbid Obesity with Obstructive Sleep Apnea.
Tirado R; Masdeu MJ; Vigil L; Rigla M; Luna A; Rebasa P; Pareja R; Hurtado M; Caixàs A
Obes Surg; 2017 Sep; 27(9):2338-2346. PubMed ID: 28283920
[TBL] [Abstract][Full Text] [Related]
27. More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity.
Zhang C; Zhang J; Liu Z; Zhou Z
Obes Surg; 2018 Nov; 28(11):3658-3668. PubMed ID: 30187424
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis.
Yan G; Wang J; Zhang J; Gao K; Zhao Q; Xu X
PLoS One; 2019; 14(12):e0224828. PubMed ID: 31794559
[TBL] [Abstract][Full Text] [Related]
30. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
Andreelli F; Amouyal C; Magnan C; Mithieux G
Diabetes Metab; 2009 Dec; 35(6 Pt 2):499-507. PubMed ID: 20152734
[TBL] [Abstract][Full Text] [Related]
31. The Importance of Glycaemic Control Before Bariatric Surgery: Preventing Microvascular and Metabolic Complications.
Sankar A; Mudaliar RN; Kochhar RS; Summers LKM; Syed AA; Majeed W
Obes Surg; 2024 Jun; 34(6):2248-2249. PubMed ID: 38400944
[No Abstract] [Full Text] [Related]
32. The role of bariatric surgery to treat diabetes: current challenges and perspectives.
Koliaki C; Liatis S; le Roux CW; Kokkinos A
BMC Endocr Disord; 2017 Aug; 17(1):50. PubMed ID: 28797248
[TBL] [Abstract][Full Text] [Related]
33. Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery.
Andrew CA; Umashanker D; Aronne LJ; Shukla AP
Curr Obes Rep; 2018 Jun; 7(2):139-146. PubMed ID: 29637413
[TBL] [Abstract][Full Text] [Related]
34. Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery.
Yamamoto H; Kaida S; Yamaguchi T; Murata S; Tani M; Tani T
Surg Today; 2016 Mar; 46(3):268-74. PubMed ID: 25700844
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Surgery and Diabesity: a Systematic Review.
El Khoury L; Chouillard E; Chahine E; Saikaly E; Debs T; Kassir R
Obes Surg; 2018 Jul; 28(7):2069-2077. PubMed ID: 29679334
[TBL] [Abstract][Full Text] [Related]
36. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.
Gastaldelli A; Iaconelli A; Gaggini M; Magnone MC; Veneziani A; Rubino F; Mingrone G
Diabetes Care; 2016 Nov; 39(11):1925-1931. PubMed ID: 27573937
[TBL] [Abstract][Full Text] [Related]
37. In-and-Out Molecular Changes Linked to the Type 2 Diabetes Remission after Bariatric Surgery: An Influence of Gut Microbes on Mitochondria Metabolism.
Samczuk P; Hady HR; Adamska-Patruno E; Citko A; Dadan J; Barbas C; Kretowski A; Ciborowski M
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477251
[TBL] [Abstract][Full Text] [Related]
38. Comment on: insulin sensitivity during first months after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels.
Ikramuddin S
Surg Obes Relat Dis; 2010; 6(4):345-6. PubMed ID: 20627711
[No Abstract] [Full Text] [Related]
39. Bariatric surgery for diabetes treatment: why should we go rapidly to surgery.
Laville M; Disse E
Diabetes Metab; 2009 Dec; 35(6 Pt 2):562-3. PubMed ID: 20152744
[TBL] [Abstract][Full Text] [Related]
40. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
Nestvold TK; Nielsen EW; Lappegård KT
Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
